SSRIs in pregnancy: risk of early infant morbidity and mortality

July 2012
Reactions Weekly;7/14/2012, Issue 1410, p2
The article deals with a study conducted in Western Australia which revealed that morbidity and mortality in early years of life are increased by maternal use of selective serotonin re-uptake inhibitors (SSRIs) during pregnancy.


Related Articles

  • Adverse effects of SSRIs taken during pregnancy. Thomas, Jack // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p75 

    The article reports on the study that investigates the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy, which reveals that utero-exposed newborns had increased risk of admission to the neonatal intensive care unit.

  • SSRI use during pregnancy proliferating.  // PharmacoEconomics & Outcomes News;5/31/2008, Issue 554, p9 

    The article reports on the increase in use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy between 1995 and 2004, according to a population-based cohort study from the Netherlands.

  • Treatment with SSRIs during pregnancy increased risk for preterm birth. Thomas, Jack // Australian Journal of Pharmacy;Aug2012, Vol. 93 Issue 1107, p88 

    The article presents information on the risk of Selective serotonin reuptake inhibitors (SSRIs) treatment during pregnancy.

  • Teratogenic risk of SSRIs used during pregnancy. Huffman, Grace Brooke // American Family Physician;7/1/1998, Vol. 58 Issue 1, p243 

    Presents a summary of the article `Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors,' by N.A. Kulin and others, which was published in the February 25, 1998, issue of the `Journal of the American Medical Association.' Examination of the pregnancy...

  • Corrections.  // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Mar2013, Vol. 98 Issue 2, pF180 

    A correction to the article "Maternal use of SSRIs, SNRIs and NaSSAs:Practical Recommendations During Pregnancy and Lactation" that was published in a previous issue of the journal is presented.

  • Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy: response. Jerome, Laurence; Jerome, L // Canadian Journal of Psychiatry;Jun2001, Vol. 46 Issue 5, p452 

    A response from the author of the article "Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy" which was published in a previous issue is presented.

  • Venlafaxine, SSRIs safe in early pregnancy.  // Reactions Weekly;May2015, Vol. 1549 Issue 1, p12 

    The article reports on the findings of a sibling-controlled cohort study which indicate that treatment with selective serotonin reuptake inhibitors and venlafaxine in early pregnancy does not cause cardiac or other birth defects.

  • British Journal of Clinical Pharmacology.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article focuses on a research, according to which the use of selective serotonin re-uptake inhibitor antidepressants during pregnancy is linked with increased risk of pregnancy induced high blood pressure.

  • Affective Disorders.  // Current Medical Literature: Psychiatry;2010, Vol. 21 Issue 1, p21 

    The reviews several articles including "Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study," by L. H. Pedersen et al., which appeared in the periodical "BMJ," "Venlafaxine in human breast milk and nursing infant plasma: determination...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics